Aarti Drugs logo

Aarti Drugs

AARTIDRUGS NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹3,906 Cr
Volatility
Moderate
P/E Ratio
20.45
EBITDA
₹312 Cr
Return on Equity
12.58%
Debt to Equity
0.37
Book Value
₹169.7
EPS
₹17.06
52W High
₹534.55
52W Low
₹318.95

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

6
  • Stock is trading at 2.53 times its book value
  • Promoter holding has decreased over last quarter: -0.60%
  • The company has delivered a poor sales growth of 3.55% over past five years.
  • Company has a low return on equity of 13.3% over last 3 years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 6.72% of profits over last 3 years

Growth Rate

Revenue Growth
6.84% higher than 3Y
Net Income Growth
15.94% higher than 3Y
Cash Flow Change
3.66% higher than 3Y
ROE
2.44% lower than 3Y
ROCE
-9.33% higher than 3Y
EBITDA Margin (Avg.)
-3.88% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
661
642
606
620
555
598
557
677
591
653
602
720
703
Expenses
577
565
536
534
490
531
495
583
516
569
547
624
605
Operating Profit
84
76
70
86
65
67
62
93
74
84
55
96
98
OPM %
13%
12%
12%
14%
12%
11%
11%
14%
13%
13%
9%
13%
14%
Other Income
1
1
2
1
1
1
12
2
0
0
1
1
-1
Interest
9
8
8
9
9
9
9
9
9
8
9
8
9
Depreciation
13
13
13
14
13
14
14
15
15
16
18
18
18
PBT
64
56
52
64
44
46
51
71
51
60
29
70
69
Tax %
24%
30%
29%
26%
24%
24%
27%
12%
-6%
25%
-40%
21%
28%
Net Profit
48
40
37
47
33
35
37
63
54
45
41
55
50
EPS in Rs
5.17
4.31
3.99
5.15
3.62
3.84
4.06
6.89
5.91
4.96
4.44
6.05
5.5
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1,097
1,140
1,195
1,244
1,561
1,806
2,155
2,489
2,716
2,529
2,387
2,565
2,678
Expenses
925
960
1,005
1,042
1,350
1,541
1,714
2,156
2,407
2,208
2,097
2,254
2,344
Operating Profit
172
180
190
202
211
266
440
333
309
321
290
312
333
OPM %
16%
16%
16%
16%
14%
15%
20%
13%
11%
13%
12%
12%
12%
Other Income
1
0
4
1
6
6
5
11
2
4
16
2
1
Interest
42
48
40
38
44
37
26
24
37
38
39
36
34
Depreciation
31
37
38
40
43
49
50
50
50
51
56
67
71
PBT
100
95
116
125
131
185
369
270
224
236
212
211
229
Tax %
23%
28%
29%
34%
32%
24%
24%
24%
26%
27%
21%
8%
—
Net Profit
77
69
82
82
90
141
280
205
166
172
168
195
191
EPS in Rs
7.97
7.09
8.57
8.73
9.52
15.17
30.09
22.14
17.96
18.65
18.42
21.36
20.95
Div. Payout %
41%
24%
3%
3%
3%
3%
8%
5%
6%
5%
5%
9%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
24
24
24
24
24
23
93
93
93
92
91
91
Reserves
284
333
376
432
520
629
820
944
1,100
1,190
1,278
1,458
Borrowings
448
483
480
546
507
389
351
543
609
564
615
577
Other Liabilities
248
261
311
388
405
535
502
629
620
587
591
690
Total Liabilities
1,004
1,102
1,191
1,389
1,455
1,576
1,766
2,208
2,421
2,432
2,575
2,815
Fixed Assets
448
493
581
602
625
644
665
690
676
811
866
1,086
CWIP
16
34
14
28
33
12
19
77
210
261
330
214
Investments
5
5
12
11
12
13
17
19
19
20
22
27
Other Assets
534
570
584
748
785
907
1,064
1,422
1,516
1,340
1,356
1,488
Total Assets
1,004
1,102
1,191
1,389
1,455
1,576
1,766
2,208
2,421
2,432
2,575
2,815
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
105
133
175
70
143
251
155
70
133
359
245
254
Investing
-107
-99
-107
-74
-62
-33
-72
-150
-164
-224
-165
-173
Financing
1
-33
-68
4
-80
-215
-81
92
17
-136
-82
-77
Net Cash Flow
-1
1
0
0
1
2
2
13
-14
-1
-2
3
Free Cash Flow
-2
34
68
-5
80
214
78
-82
-31
133
67
80
CFO/OP
69
85
103
47
82
110
57
46
62
131
103
80
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
105
106
91
110
107
99
94
110
116
102
115
118
Inventory Days
82
86
100
132
86
102
117
115
101
107
114
112
Days Payable
83
90
94
123
85
104
93
103
94
94
100
109
Cash Conversion Cycle
104
103
97
119
109
97
118
123
123
115
129
121
Working Capital Days
14
19
22
33
44
54
77
63
72
74
76
76
ROCE %
—
18%
18%
17%
17%
21%
34%
21%
15%
15%
13%
12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Aarti Drugs insights

67 extracted metrics + investor summaries across FY06–FY27.

Log in — free

Shareholding Pattern

FIIs1.52%Promot.54.43%Others9.63%DIIs10.29%Public24.12%As ofJun 2026
2.50% of promoter holding pledged as of Jun 2026

Documents

Frequently Asked Questions about Aarti Drugs

What does Aarti Drugs Ltd do?
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations. [1] It is exporting its API's and Spec...
Where is Aarti Drugs Ltd (AARTIDRUGS) listed?
Aarti Drugs Ltd trades as AARTIDRUGS on the NSE and under code 524348 on the BSE.
Which sector does Aarti Drugs Ltd belong to?
Aarti Drugs Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Aarti Drugs Ltd?
Aarti Drugs Ltd has a market capitalisation of ₹3,906 Cr, which places it in the Small Cap band.
What is the PE ratio of Aarti Drugs Ltd?
Aarti Drugs Ltd trades at a PE ratio of 20.45, on earnings per share of ₹17.06, against a book value of ₹169.7 per share.
What is the 52-week high and low of Aarti Drugs Ltd?
Over the last 52 weeks Aarti Drugs Ltd has traded between ₹318.95 and ₹534.55.
Does Aarti Drugs Ltd pay dividends?
Aarti Drugs Ltd has a dividend yield of 0.46%.
What is the Return on Equity (ROE) of Aarti Drugs Ltd?
Aarti Drugs Ltd reported a return on equity of 12.58%. Its debt-to-equity ratio is 0.37.

Company Information

Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations. [1] It is exporting its API's and Speciality chemicals to over 100 countries across the globe. [2]

Website aartidrugs.com
CEO Mr. Prakash Moreshwar Patil
Employees 1,284
Listed 2003-09-19
Face Value ₹ 10
Issued Size 9,12,70,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AARTIDRUGS.md for Aarti Drugs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List